Table of Contents Table of Contents
Previous Page  706 / 916 Next Page
Information
Show Menu
Previous Page 706 / 916 Next Page
Page Background

S702

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S645–S709

Case report

Mrs. W. is a 28-year-old mother of three children. In

her medical history, she was diagnosed with gestational diabetes

and treated briefly with insulin. She was hospitalized several times

for hypoglycemia and she was diagnosed with factitious disorder.

Lately, her youngest daughter aged 2 years old was hospitalized

in the pediatric department for repeated unexplained loss of con-

sciousness. The hospitalization lasted 2 months with recurrence of

severe hypoglycemia. A full metabolic screen revealed no abnor-

malities. The mood of the mother appeared quite discordant with

the situation. Strict monitoring of maternal behavior showed that

the mother gives insulin injections to her daughter. She denied

deliberately injecting insulin, and then she accused the health

workers. She was referred to our psychiatric department and we

diagnosed the MSBP.

Conclusion

MSBP should be considered particularly in patients

who have been evaluated by more than one hospital and have

discordant test results.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1244

EV0915

Which one is the best anaesthetic

agent for Ect?

H. Saiz Garcia

1 ,

, L. Montes Reula

1

, A. Portilla Fernandez

1

,

V. Pereira Sanchez

2

, N. Olmo Lopez

3

, E. Mancha Heredero

1

,

A.S. Rosero Enriquez

1

, M.E. Martinez Parre˜no

1

1

Complejo Hospitalario Navarra, Psychiatry, Pamplona, Spain

2

Clinica Universidad Navarra, Psychiatry, Pamplona, Spain

3

CSM Salburua, Psychiatry, Vitoria, Spain

Corresponding author.

Introduction

The most frequently used anesthesiologic agents

are methohexital, thiopental, etomidate, propofol, ketamine, and

sevoflurane. The objective is to clarify the differences on recov-

ery, cardiovascular variables, cognitive functions, and response to

treatment showed by these drugs.

Methods

A review was conducted aiming to clarify the differ-

ences between anaesthetic agnets used in ECT. The literature search

was conducted in PubMed data reviewing articles dating between

2015 and 2016.

Results

– Propofol seems to have better hemodynamic effects

in comparison with etomidate in patients with schizophrenia and

depression;

– The seizure duration was significantly shorter with propofol, but

this did not cause a difference regarding clinical improvement;

– The seizure duration was longer with etomidate in many studies.

It did not decrease in a dose-dependent fashion with etomidate in

a study comparing methohexital, etomidate, and propofol;

– The most frequently observed adverse effects were arrhythmias

and nausea and they occurred more frequently in patients who

were given thiopental. The pain at the injection site was more

frequent in patients who were given propofol;

– Etomidate seems to have better clinical improvement than

thiopental. Thiopental seems to have better results than propofol,

which has an anticonvulsant feature effects.

Conclusions

In order to figure out which anaesthetic agent was

the most indicated for undergoing ECT, we found that both EEG-

based seizure duration and motor seizure duration showed the

sequence etomidatemethohexical>thio- pental>propofol. These

items are directly related with clinical improvement. When a drug

is chosen, It is important to individualize the treatment according

to the patients’ comobidity.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1245

EV0916

Neuroacanthocytosis syndromes and

neuropsychiatry symptoms associated

H. Saiz Garcia

1 ,

, L. Montes Reula

1

, A. Portilla Fernandez

1

,

V. Pereira Sanchez

2

, N. Olmo Lopez

3

, E. Mancha Heredero

1

,

A.S. Rosero Enriquez

1

1

Complejo Hospitalario Navarra, Psychiatry, Pamplona, Spain

2

Clinica Universidad de Navarra, Psychiatry, Pamplona, Spain

3

CSM Salburua, Psychiatry, Vitoria, Spain

Corresponding author.

Introduction

Neuroacanthocytosis is an infrequent cause of both

neurological and psychiatric manifestations, and acanthocytes,

which are a special form of spiculated red blood cells. Clinically sig-

nificant psychopathology, ranging from behavioural disturbance to

frank psychiatric illness, has been reported to occur in up to 60% of

ChAc patients.

Methods

A review was conducted aiming to clarify the phys-

iopathology of this illness and its clinical features in order to

distinguish neuroacanthocytosis from other neurological or psy-

chiatric diseases. The literature search was conducted in PubMed

data reviewing articles dating between 2010 and 2016.

Results

– Neuroacanthocytosis autosomal recessive disorder

associated with mutations or deletions in the VPS13A gene on

chromosome 9q, which codes for the membrane protein chorein.

Chorein is strongly expressed in the brain. Chorein loss particu-

larly affects the basal ganglia, especially the caudate nucleus and

putamen;

– Dysexecutive syndromes, OCD, depression and possibly psy-

chosis, which may precede the frank motor and cognitive

impairment;

– The most recently developed treatment for neuroacanthocytoses

is the use of deep-brain stimulation (DBS), with stimulation of the

globus pallidus internus.

Conclusions

While conducting a neurological exam, secondary

causes of psychosis have to be included in the differential diagno-

sis. It is important to notice the possible confusion between tardive

dyskinesia and a primary movement disorder. It should be neces-

sary to investigate all de novo movement disorders in psychotic

patients in order to eliminate etiologies other than iatrogenic ones.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.1246

EV0917

A review about comorbidity between

obsessive-compulsive symptoms and

huntintong disease and a case report

L. Sánchez Blanco

1 ,

, M. Juncal Ruíz

1

,

G. Pardo de Santayana Jenaro

1

, M. Goméz Revuelta

2

,

R. Landera Rodríguez

1

, O. Porta Olivares

1

, D. Abejas Díez

1

,

N.I. Nú˜nez Morales

1

1

Hospital Universitario Marqués de Valdecilla, Psychiatry,

Santander, Spain

2

Hospital Universitario de Álava-sede Santiago, Psychiatry,

Vitoria-Gasteiz, Spain

Corresponding author.

Introduction

The concept of obsessive-compulsive disorder

(OCD) as a disorder that affects the basal ganglia arising to the

phenomenological similarities found between idiopathic OCD and

other conditions associated with basal ganglia disease such as

Huntington’s disease (HD) and Sydenham’s chorea. Huntintong’s

disease is characterized by cognitive, motor and neuropsychiatric

symptoms.

Aims

A review of articles published from 1989 to 2016 in Pub-

Med and UpToDate about relationship between HD and obsessive-

compulsive symptoms.